Benzoxazole derivatives and drugs containing the same as the active ingredient
A compound represented by the following general formula (1): wherein R 1 represents a halogen atom, R 2 represents hydrogen atom or a lower alkyl group, and R 3 represents hydrogen atom, a lower alkyl group, a lower alkoxyl group, a hydroxy lower alkyl group, a halogen atom, or a substituted or unsubstituted amino group, wherein a substituent on the amino group is selected from the group consisting of a lower alkyl group, a lower alkenyl group, a lower alkylcarbonyl group, and an amino protective group, or a salt thereof. The compound of the present invention or a salt thereof is useful as an active ingredient of medicaments for preventive and/or therapeutic treatment of conditions of irritable bowel syndrome and digestive tract functional disorder, or condition of diarrhea.
1. 5-Chloro-2-(1-homopiperazinyl)-7-methylbenzoxazole or a salt thereof.
2. A pharmaceutical composition which comprises, as an active ingredient, an effective amount of a substance selected from the group consisting of the compound according to claim 1 , a pharmaceutically acceptable salt thereof, a hydrate thereof, and a solvate thereof.
3. A method for the manufacture of the pharmaceutical composition according to claim 2 , which comprises mixing the substance selected from the group consisting of 5-chloro-2-(1-homopiperazinyl)-7-methylbenzoxazole, a pharmaceutically acceptable salt thereof, a hydrate thereof and a solvate thereof, with a pharmaceutical carrier.
4. A method for therapeutic treatment of condition of irritable bowel syndrome or digestive tract functional disorder, or condition of diarrhea, which comprises a step of administering to a mammal including human a therapeutically effective amount of a substance selected from the group consisting of the compound according to claim 1 , a pharmaceutically acceptable salt thereof, a hydrate thereof, and a solvate thereof.
5. A serotonin 5-HT 3 receptor antagonistic agent or partial activator for therapeutic treatment of condition of irritable bowel syndrome or digestive tract functional disorder, or condition of diarrhea, comprising as an active ingredient, an effective amount of a substance selected from the group consisting of 5-chloro-2-(1′-homopiperazinyl)-7-methylbenzoxazole, a pharmaceutically acceptable salt thereof, a hydrate thereof, and a solvate thereof.